Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study
Liyang Hu(Sun Yat-sen University), Qingqing Cai(Sun Yat-sen University)
Cited by 56
Related Papers
BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma
|Cancer Communications|2020|51
EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47
|Journal of Thoracic Oncology|2024|46